- Sight Sciences
We aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent
- Sight Sciences, Inc. (SGHT) - Yahoo Finance
Find the latest Sight Sciences, Inc (SGHT) stock quote, history, news and other vital information to help you with your stock trading and investing
- Experience the Ergo-Series of the OMNI® Surgical System
The OMNI® Surgical System from Sight Sciences is the first and only glaucoma device indicated for canaloplasty followed by trabeculotomy for patients with primary open-angle glaucoma
- Sight Sciences - 2025 Company Profile Team - Tracxn
Explore Sight Sciences' in-depth company profile, including funding details, key investors, leadership, and competitors
- Sight Sciences - Eyetube
Discover the largest ophthalmic surgical video library of narrated, physician-created content on cataract, cornea, retina, glaucoma, and refractive procedures
- Sight Sciences - Crunchbase Company Profile Funding
Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease
- Sight Sciences | United States
So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent We have embarked on a journey to reimagine the landscape of eyecare
- Sight Sciences (SGHT) Company Profile Description
Sight Sciences, Inc , an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases The company operates in two segments, Surgical Glaucoma and Dry Eye
|